GlaxoSmithKline faces fresh drug bribery claims in Syria

14th August 2014

Pharmaceutical firm investigating new claims of bribing doctors made in anonymous email sent to its top managers last week.

GlaxoSmithKline faces new allegations that it bribed Syrian doctors and officials to boost sales of its medicines, following recent accusations of corruption in its non-prescription business in the country.

Read more at source article www.theguardian.com


Leave a Reply

Your email address will not be published.

64 − = 56

« back to posts